Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$3.65
-0.5%
$4.32
$3.27
$7.63
$467.55M1.41711,317 shs424,927 shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.16
+2.7%
$1.18
$0.97
$2.74
$439.62M1.542.27 million shs693,274 shs
Quantum-Si incorporated stock logo
QSI
Quantum-Si
$1.15
-0.9%
$1.41
$0.61
$5.77
$210.61M2.719.66 million shs1.63 million shs
Transcat, Inc. stock logo
TRNS
Transcat
$84.59
+1.8%
$76.97
$67.56
$147.12
$787.45M0.6773,468 shs95,880 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-0.54%+3.69%-13.92%-33.15%-38.34%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
+2.65%+5.45%0.00%-34.46%-55.56%
Quantum-Si incorporated stock logo
QSI
Quantum-Si
-0.86%-1.71%-27.67%-48.66%-24.84%
Transcat, Inc. stock logo
TRNS
Transcat
+1.77%+9.52%+18.69%-15.70%-19.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
1.8362 of 5 stars
3.22.00.00.03.31.70.0
Standard BioTools Inc. stock logo
LAB
Standard BioTools
2.1663 of 5 stars
3.32.00.00.00.64.20.6
Quantum-Si incorporated stock logo
QSI
Quantum-Si
1.8059 of 5 stars
3.32.00.00.00.62.50.6
Transcat, Inc. stock logo
TRNS
Transcat
2.6764 of 5 stars
3.21.00.00.03.13.31.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.33
Hold$6.4275.80% Upside
Standard BioTools Inc. stock logo
LAB
Standard BioTools
2.50
Moderate Buy$2.50115.52% Upside
Quantum-Si incorporated stock logo
QSI
Quantum-Si
2.67
Moderate Buy$3.48202.17% Upside
Transcat, Inc. stock logo
TRNS
Transcat
2.40
Hold$111.5031.81% Upside

Current Analyst Ratings Breakdown

Latest QSI, TRNS, CTKB, and LAB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/19/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$6.00 ➝ $6.00
3/5/2025
Quantum-Si incorporated stock logo
QSI
Quantum-Si
National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$3.65
3/5/2025
Quantum-Si incorporated stock logo
QSI
Quantum-Si
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/4/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$8.50 ➝ $8.00
2/27/2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Sector Weight
2/7/2025
Quantum-Si incorporated stock logo
QSI
Quantum-Si
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$3.75
2/2/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$5.25
1/31/2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Sell$7.00 ➝ $4.50
1/29/2025
Transcat, Inc. stock logo
TRNS
Transcat
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$126.00 ➝ $106.00
1/29/2025
Transcat, Inc. stock logo
TRNS
Transcat
Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform$110.00 ➝ $85.00
1/29/2025
Transcat, Inc. stock logo
TRNS
Transcat
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$200.45M2.33$0.02 per share206.16$2.90 per share1.26
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$174.43M2.52N/AN/A($1.85) per share-0.63
Quantum-Si incorporated stock logo
QSI
Quantum-Si
$3.06M68.87N/AN/A$1.92 per share0.60
Transcat, Inc. stock logo
TRNS
Transcat
$272.20M2.89$3.12 per share27.14$30.19 per share2.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$12.15M-$0.05N/AN/A-5.05%-2.58%-2.05%5/6/2025 (Estimated)
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$74.66M-$0.55N/AN/AN/A-79.92%-27.05%-15.52%5/6/2025 (Estimated)
Quantum-Si incorporated stock logo
QSI
Quantum-Si
-$95.96M-$0.71N/AN/AN/A-3,968.84%-36.96%-33.57%5/8/2025 (Estimated)
Transcat, Inc. stock logo
TRNS
Transcat
$13.65M$1.8545.7232.16N/A6.22%7.23%5.67%5/19/2025 (Estimated)

Latest QSI, TRNS, CTKB, and LAB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.04N/AN/AN/A$43.18 millionN/A
5/14/2025Q1 2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$0.04N/AN/AN/A$40.10 millionN/A
5/8/2025Q1 2025
Quantum-Si incorporated stock logo
QSI
Quantum-Si
-$0.17N/AN/AN/A$0.96 millionN/A
1/27/2025Q3 2025
Transcat, Inc. stock logo
TRNS
Transcat
$0.38$0.45+$0.07$0.25$70.30 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
Quantum-Si incorporated stock logo
QSI
Quantum-Si
N/AN/AN/AN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
6.21
5.47
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
3.76
3.41
Quantum-Si incorporated stock logo
QSI
Quantum-Si
N/A
13.42
13.15
Transcat, Inc. stock logo
TRNS
Transcat
0.14
2.42
1.98

Institutional Ownership

CompanyInstitutional Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%
Quantum-Si incorporated stock logo
QSI
Quantum-Si
39.90%
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
9.60%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.10%
Quantum-Si incorporated stock logo
QSI
Quantum-Si
30.04%
Transcat, Inc. stock logo
TRNS
Transcat
2.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500128.10 million116.45 millionOptionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
620378.99 million174.59 millionOptionable
Quantum-Si incorporated stock logo
QSI
Quantum-Si
150183.14 million99.84 millionOptionable
Transcat, Inc. stock logo
TRNS
Transcat
9209.31 million9.10 millionOptionable

Recent News About These Companies

Analysts Set Transcat, Inc. (NASDAQ:TRNS) Price Target at $111.50
Transcat Is Nearing An Inflection Point
Transcat price target lowered to $106 from $126 at H.C. Wainwright
Transcat Prepares for Q3 FY2025 Financial Results
Transcat, Inc. (TRNS) Q3 2025 Earnings Call Transcript
Craig-Hallum Releases a Buy Rating on Transcat (TRNS)
Transcat sees FY25 service organic revenue up mid-to-low single digits

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$3.65 -0.02 (-0.54%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$3.64 0.00 (-0.14%)
As of 04/17/2025 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$1.16 +0.03 (+2.65%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.14 -0.02 (-2.07%)
As of 04/17/2025 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Quantum-Si stock logo

Quantum-Si NASDAQ:QSI

$1.15 -0.01 (-0.86%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.14 -0.01 (-1.30%)
As of 04/17/2025 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

Transcat stock logo

Transcat NASDAQ:TRNS

$84.59 +1.47 (+1.77%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$84.52 -0.08 (-0.09%)
As of 04/17/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.